Literature DB >> 25000824

Factors associated with patency following angioplasty of hemodialysis fistulae.

Brendon L Neuen1, Ronny Gunnarsson2, Richard A Baer3, Patrik Tosenovsky4, Stella J Green3, Jonathan Golledge5, Murty L Mantha3.   

Abstract

PURPOSE: Patency after percutaneous transluminal angioplasty of native hemodialysis arteriovenous fistulae (AVFs) is highly variable. This study aimed to identify predictors of patency following angioplasty in native AVFs.
MATERIALS AND METHODS: All endovascular procedures performed in native AVFs between 2005 and 2013 at two institutions were retrospectively reviewed. Clinical, anatomic, biochemical, and medication variables were subjected to univariate and multivariate Cox regression analysis to identify predictors of postintervention primary and secondary patency.
RESULTS: During the study period, 207 patients underwent first angioplasty of their AVF. Follow-up ranged from 14 days to 8 years, during which another 247 endovascular interventions were performed to maintain patency. Postintervention primary patency rates at 6, 12, and 24 months were 66%, 49%, and 29%, respectively. Postintervention secondary patency rates at 6, 12, and 24 months were 94%, 84%, and 79%, respectively. On multivariate adjusted Cox regression analysis, upper-arm AVFs (P = .00072), AVFs less than 6 months of age (P = .0014), presence of multiple stenoses (P = .019), and degree of initial stenosis (P = .016) were significantly associated with shorter postintervention primary patency. A previously failed AVF was the only significant predictor of postintervention secondary patency loss (P = .0053).
CONCLUSIONS: Anatomic factors related to the AVF location, AVF age, and the extent of the lesion are important predictors of restenosis after balloon angioplasty. Traditional cardiovascular risk factors, metabolic and inflammatory markers, and medications were not associated with postintervention patency.
Copyright © 2014 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25000824     DOI: 10.1016/j.jvir.2014.05.020

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  6 in total

1.  Percutaneous Transluminal Angioplasty of Dysfunctional Hemodialysis Vascular Access: Can Careful Selection of Patients Improve the Outcomes?

Authors:  Tahir Khan; Mudasir Bhat; Omair A Shah; Naseer A Choh; Shadab Maqsood; Tahleel A Shera
Journal:  Indian J Nephrol       Date:  2022-03-16

2.  Serum Indoxyl Sulfate Associates with Postangioplasty Thrombosis of Dialysis Grafts.

Authors:  Chih-Cheng Wu; Mu-Yang Hsieh; Szu-Chun Hung; Ko-Lin Kuo; Tung-Hu Tsai; Chao-Lun Lai; Jaw-Wen Chen; Shing-Jong Lin; Po-Hsun Huang; Der-Cherng Tarng
Journal:  J Am Soc Nephrol       Date:  2015-10-09       Impact factor: 10.121

Review 3.  Impact of Indoxyl Sulfate on Progenitor Cell-Related Neovascularization of Peripheral Arterial Disease and Post-Angioplasty Thrombosis of Dialysis Vascular Access.

Authors:  Chih-Cheng Wu; Szu-Chun Hung; Ko-Lin Kuo; Der-Cherng Tarng
Journal:  Toxins (Basel)       Date:  2017-01-07       Impact factor: 4.546

4.  Predictors associated with early and late restenosis of arteriovenous fistulas and grafts after percutaneous transluminal angiography.

Authors:  Quan Zheng; Bingying Xie; Xinfu Xie; Wenhao Zhang; Jihua Hou; Zhonglin Feng; Yiming Tao; Feng Yu; Li Zhang; Zhiming Ye
Journal:  Ann Transl Med       Date:  2021-01

5.  Drug-eluting balloon (DEB) versus plain old balloon angioplasty (POBA) in the treatment of failing dialysis access: A prospective randomized trial.

Authors:  Torbjörn Fransson; Anders Gottsäter; Mohammad Abdulrasak; Martin Malina; Timothy Resch
Journal:  J Int Med Res       Date:  2022-03       Impact factor: 1.671

6.  Endovascular Stent Placement for Hemodialysis Arteriovenous Access Stenosis.

Authors:  Brendon L Neuen; Richard A Baer; Frank Grainer; Murty L Mantha
Journal:  Int J Vasc Med       Date:  2015-11-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.